Assignee
NEPHRON PHARMACEUTICALS CORP
US·2 granted patents·7 pending applications·0 citations·filing 2014–2023
Top patents by PatentIndex Score
9 records- 0156US12303520B2Aqueous nebulization compositionNEPHRON PHARMACEUTICALS CORP·Filed 2022·Granted May 20, 2025·0 cites·23 claims
- 0254US2023346766A1Tiotropium inhalation solution for nebulizationNEPHRON PHARMACEUTICALS CORP·Filed 2023·Application pending·0 cites
- 0348US11344562B2Aqueous nebulization compositionNEPHRON PHARMACEUTICALS CORP·Filed 2018·Granted May 31, 2022·0 cites·18 claims
- 0445US2015119455A1FormulationNEPHRON PHARMACEUTICALS CORP·Filed 2014·Application pending·0 cites
- 0545US2016271097A1Formulation of olopatadineNEPHRON PHARMACEUTICALS CORP·Filed 2014·Application pending·0 cites
- 0631US2019290633A1Tiotropium Inhalation Solution for NebulizationNEPHRON PHARMACEUTICALS CORP·Filed 2018·Application pending·0 cites
- 0731US2019231769A1Tiotropium Inhalation Solution for NebulizationNEPHRON PHARMACEUTICALS CORP·Filed 2018·Application pending·0 cites
- 0827US2022165384A1Blockchain systems and methods for remote monitoringNEPHRON PHARMACEUTICALS CORP·Filed 2020·Application pending·0 cites
- 0911US2015202308A1Budesonide formulationNEPHRON PHARMACEUTICALS CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEPHRON PHARMACEUTICALS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →